Thought Leadership - MarketScan
This is a general thought-leadership hub page for Merative's MarketScan real-world data products, not an Organon-specific case study — it covers claims data analysis, EHR/claims linking (with Veradigm), a mortality database, NLP-enhanced analysis, employer claims data, and closed-claims rare-disease research, with a featured Lantern case study on elective-surgery price variation. No content specific to Organon or "cloud-based real-world data access" was found on the fetched page.
Merative is the former IBM Watson Health, now an independent company behind the MarketScan claims database and the Zelta clinical-trial platform.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Merative on its own site — read the original case study on merative.com ↗
Note: Fetched page is a general MarketScan resource hub, not an Organon-specific case study; no Organon-specific content was found.
Related use cases
- 01Boehringer Ingelheim case study
- 02How one Canadian research center increased their sample size and strengthened insights
- 03Examining Variations in Elective Surgery Prices Across the U.S.
- 04Getting ahead of drug supply challenges
- 05Veristat Case Study
- 06served its expanding clientele with a modular clinical development solution